Stage IV prostate cancer in Guadeloupe, a French Caribbean archipelago - Abstract

OBJECTIVES: To study clinical characteristics, in terms of survival and response to treatment, of patients with non-localized prostate cancer at diagnosis in an Afro-Caribbean population from Guadeloupe.

METHODS: Cases of stage IV prostate cancer (T4N0M0, TxN1M0 and TxNxM1) at diagnosis in the Pointe à Pitre Hospital were selected from 1995 to 2012 and studied.

RESULTS: One hundred and eighty-three patients were included. Median age at diagnosis was 70.3 years old (79.2% were more than 65years). A total of 81.5% of them was TxNxM1 and 11.5% was TxN1M0. Median disease free survival was 18.5 months. Median overall survival was 49.0months.

CONCLUSION: This study about non-localized prostate cancer at diagnosis in an Afro-Caribbean population from a French Caribbean archipelago seemed to show no difference with general population suffering from the same disease, although prostate cancer incidence in this area is one of the highest in the world.

Written by:
Casenave J, Sénéchal C, Nevoux P, Gourtaud G, Tressières B, Blanchet P.   Are you the author?
Service d'urologie et de transplantation rénale, CHU de Pointe à Pitre, 97159 Pointe à Pitre, Guadeloupe; Centre d'investigation clinique-épidémiologie clinique Antilles/Guyane, CHU de Pointe à Pitre, 97159 Pointe à Pitre, Guadeloupe.

Reference: Prog Urol. 2014 Mar;24(3):167-72.
doi: 10.1016/j.purol.2013.08.311


PubMed Abstract
PMID: 24560205

Article in French.

UroToday.com Prostate Cancer Section